US Patent 8859514 Modulation of C-reactive protein expression
Patent 8859514 was granted and assigned to Ionis Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8859514 Modulation of C-reactive protein expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
